1. A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing. Issue 21 (17th May 2018) Authors: Bockstal, Viki; Sanders, Barbara; Achterberg, Rogier; Tiemessen, Machteld; Bogaert, Lies; Van der Meer, Marjolein; Schuitemaker, Hanneke; Zahn, Roland Journal: Vaccine Issue: Volume 36:Issue 21(2018) Page Start: 2917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses. Issue 30 (16th July 2018) Authors: Vujadinovic, Marija; Khan, Selina; Oosterhuis, Koen; Uil, Taco G.; Wunderlich, Kerstin; Damman, Sarra; Boedhoe, Satish; Verwilligen, Annemiek; Knibbe, Jonathan; Serroyen, Jan; Schuitemaker, Hanneke; Zahn, Roland; Scheper, Gert; Custers, Jerome; Vellinga, Jort Journal: Vaccine Issue: Volume 36:Issue 30(2018) Page Start: 4462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model. Issue 46 (12th November 2018) Authors: Bockstal, Viki; Tiemessen, Machteld M.; Achterberg, Rogier; Van Wordragen, Carlo; Knaapen, Ad M.; Serroyen, Jan; Marissen, Wilfred E.; Schuitemaker, Hanneke; Zahn, Roland Journal: Vaccine Issue: Volume 36:Issue 46(2018) Page Start: 6979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22). Issue 6 (June 2020) Authors: Stephenson, Kathryn E; Wegmann, Frank; Tomaka, Frank; Walsh, Stephen R; Tan, C Sabrina; Lavreys, Ludo; Ansel, Jessica L; Kanjilal, Diane G; Jaegle, Kate; Nkolola, Joseph P; Peter, Lauren; Fogel, Rachel; Bradshaw, Connor; Tyler, Anna; Makoni, Tatenda; Howe, Lisa; Quijada, Darla; Chandrashekar, Abi... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cytotoxic T lymphocyte responses in HIV-1-infected long-term nonprogressors: lessons for vaccine design. (July 2008) Authors: Navis, Marjon; Miedema, Frank; Schuitemaker, Hanneke Journal: Future HIV therapy Issue: Volume 2:Number 4(2008) Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease. Issue 2 (24th April 2017) Authors: Khan, Selina; Oosterhuis, Koen; Wunderlich, Kerstin; Bunnik, Evelien M.; Bhaggoe, Melissa; Boedhoe, Satish; Karia, Santusha; Steenbergen, Renske D.M.; Bosch, Leontien; Serroyen, Jan; Janssen, Sarah; Schuitemaker, Hanneke; Vellinga, Jort; Scheper, Gert; Zahn, Roland; Custers, Jerome Journal: International journal of cancer Issue: Volume 141:Issue 2(2017:Jul. 15) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease. Issue 2 (24th April 2017) Authors: Khan, Selina; Oosterhuis, Koen; Wunderlich, Kerstin; Bunnik, Evelien M.; Bhaggoe, Melissa; Boedhoe, Satish; Karia, Santusha; Steenbergen, Renske D.M.; Bosch, Leontien; Serroyen, Jan; Janssen, Sarah; Schuitemaker, Hanneke; Vellinga, Jort; Scheper, Gert; Zahn, Roland; Custers, Jerome Journal: International journal of cancer Issue: Volume 141:Issue 2(2017:Jul. 15) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials. Issue 32 (30th July 2022) Authors: Sadoff, Jerald; Le Gars, Mathieu; Brandenburg, Boerries; Cárdenas, Vicky; Shukarev, Georgi; Vaissiere, Nathalie; Heerwegh, Dirk; Truyers, Carla; de Groot, Anne Marit; Jongeneelen, Mandy; Kaszas, Krisztian; Tolboom, Jeroen; Scheper, Gert; Hendriks, Jenny; Ruiz-Guiñazú, Javier; Struyf, Frank; Van H... Journal: Vaccine Issue: Volume 40:Issue 32(2022) Page Start: 4403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Issue 10143 (21st July 2018) Authors: Barouch, Dan H; Tomaka, Frank L; Wegmann, Frank; Stieh, Daniel J; Alter, Galit; Robb, Merlin L; Michael, Nelson L; Peter, Lauren; Nkolola, Joseph P; Borducchi, Erica N; Chandrashekar, Abishek; Jetton, David; Stephenson, Kathryn E; Li, Wenjun; Korber, Bette; Tomaras, Georgia D; Montefiori, David C... Journal: Lancet Issue: Volume 392:Issue 10143(2018) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗